-
In the previous session, the BSE Sensex gained 295 points to close at 49,502, while the Nifty50 rose 119 points to 14,942
-
Growth in home loans were seen in both, the affordable housing segment as well as high-end properties
-
Benchmark equity indices extended gains for the fourth straight session as healthy buying observed in blue-chip stocks like Sun Pharma, Dr Reddy's Lab and ONGC along with mid and small-cap stocks
-
Shares of Kotak Mahindra Bank have climbed 641 times to an adjusted price of Rs 1,779.95 on May 7, 2021 from Rs 2.78 on May 9, 2001
-
Berkshire Hathaway reported nearly $12 billion profit in the first quarter a year after a major loss when the value of its stock investments plummeted because of the coronavirus pandemic
-
In the previous session, Sensex climbed 256.71 points or 0.52 per cent to finish at 49,206.47, and Nifty rose 98.35 points or 0.67 per cent to 14,823.15
-
Thyrocare reported a 28% rise in consolidated net profit to Rs 113.14 crore on a 14.2% increase in net sales to Rs 494.62 crore in the year ended 31 March 2020.
-
The scrip traded 1.46% lower at Rs 6390.20 at around 10.50 am (IST). On the other hand, the benchmark BSE Sensex was up 357 points, or 0.73%, at 49,563 at around the same time.
-
28 of 30 Sensex stocks were trading in the green. Dr Reddy's was the top gainers on the Sensex soaring 2.83%, ONGC, Kotak Mahindra Bank, Titan and L&T gained over 1%
-
Coal India is all set to continue with the supply of coal to the power plants under import substitution in the FY22.
